3-iodobenzylguanidine has been researched along with milnacipran in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Brockmöller, J; Dücker, C; Jensen, O | 1 |
Kaneko, K; Matsumura, H; Nakagome, K; Ohta, Y; Pu, S; Terachi, S; Yamada, T; Yamanashi, T; Yokoyama, K | 1 |
2 other study(ies) available for 3-iodobenzylguanidine and milnacipran
Article | Year |
---|---|
Identification of Novel High-Affinity Substrates of OCT1 Using Machine Learning-Guided Virtual Screening and Experimental Validation.
Topics: Databases, Chemical; Drug Evaluation, Preclinical; HEK293 Cells; Humans; Machine Learning; Octamer Transcription Factor-1; Organic Chemicals | 2021 |
Milnacipran influences the indexes of I-metaiodobenzylguanidine scintigraphy in elderly depressed patients.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Antidepressive Agents; Brain; Cyclopropanes; Depressive Disorder, Major; Diagnosis, Differential; Female; Humans; Lewy Body Disease; Male; Milnacipran; Radionuclide Imaging; Radiopharmaceuticals | 2014 |